𧬠ICD-10-CM K22.70 ā Barrettās Esophagus Without Dysplasia
Billable Code Confirmed
ICD-10-CM K22.70 is a valid, billable 5-character ICD-10-CM code for FY2026. The
K22category defines other diseases of the esophagus, the7character specifies Barrettās esophagus, and the0character confirms the specific absence of dysplasia. No additional characters are required.
Non-Billable Parent Codes ā Never Submit These
- ā
K22ā 3-character header ā Lacks specificity regarding the exact esophageal disease.- ā
K22.7ā 4-character header ā Lacks specificity regarding the presence or absence of dysplasia.Always submit K22.70 (all 5 characters) when Barrettās esophagus is documented and pathology confirms there is no dysplasia (or if dysplasia status is not specified, as K22.70 is the default).
Clinical Context: The Dysplasia Distinction
ICD-10-CM K22.70 captures intestinal metaplasia of the esophagus where cellular architecture remains benign (no dysplasia). Dysplasia represents a precancerous cellular change. If a pathology report indicates ālow gradeā or āhigh gradeā dysplasia, the code must be selected from the K22.71- subcategory instead.
Code Classification
ICD-10-CM Diagnosis Code ā wRVU, assistant payable, and global period fields are not applicable; direct reader to CPT Procedural Crosswalk and ICD-10-PCS Crosswalk sections.
š Code Description
ICD-10-CM K22.70 classifies Barrettās esophagus without dysplasia. This code represents a condition in which the normal stratified squamous epithelium lining the distal esophagus is abnormally replaced by columnar epithelium containing goblet cells (intestinal metaplasia), but without any precancerous cellular atypia (dysplasia).
Pathophysiologically, this metaplastic change is a protective, adaptive response to chronic mucosal injury from gastric acid and bile exposure, most commonly due to long-standing Gastro-esophageal Reflux Disease (GERD). While the columnar cells are more resistant to acid, Barrettās esophagus is a known precursor lesion for esophageal adenocarcinoma. Thus, regular endoscopic surveillance with biopsy is clinically indicated to monitor for dysplastic progression.
š³ Code Tree / Hierarchy
K22 Other diseases of esophagus ā Non-billable
ā
āāā K22.6 Gastro-esophageal laceration-hemorrhage syndrome ā
Billable
āāā K22.7 Barrett's esophagus ā Non-billable
ā ā
ā āāā K22.70 Barrett's esophagus without dysplasia ā THIS CODE ā
Billable
ā āāā K22.71 Barrett's esophagus with dysplasia ā Non-billable
ā ā
ā āāā K22.710 Barrett's esophagus with low grade dysplasia ā
Billable
ā āāā K22.711 Barrett's esophagus with high grade dysplasia ā
Billable
ā āāā K22.719 Barrett's esophagus with dysplasia, unspecified ā
Billable
ā
āāā K22.8 Other specified diseases of esophagus ā Non-billableDefault Code Status
According to the ICD-10-CM Alphabetic Index, if a provider simply documents āBarrettās esophagusā without specifying the dysplasia status, the default code assignment is K22.70. However, best practice is to always verify the pathology report and query if dysplasia is mentioned in the path but missing from the providerās final diagnosis.
ā Includes
The following clinical terms and scenarios map to K22.70 when documented:
-
Barrettās disease NOS
-
Barrettās syndrome NOS
-
Barrettās ulcer
-
Intestinal metaplasia of the lower esophagus (without dysplasia)
-
Columnar epithelium lining of the lower esophagus
ā Excludes
Excludes 1 ā Cannot Be Coded Simultaneously with K22.70
| Code | Description | Note |
|---|---|---|
| K22.71- | Barrettās esophagus with dysplasia | Mutually exclusive. A patient cannot concurrently have Barrettās both āwithā and āwithoutā dysplasia at the highest level of diagnosis; code the highest severity (dysplasia) if present. |
| C15.- | Malignant neoplasm of esophagus | Mutually exclusive. If the condition has progressed to esophageal adenocarcinoma, only the malignancy code is reported. |
Excludes 1 Violation Risk
Excludes 2 ā May Be Coded in Addition if Separately Present
| Code | Description | Note |
|---|---|---|
| K21.- | Gastro-esophageal reflux disease | May be coded simultaneously. Since GERD is the primary underlying etiology for Barrettās esophagus, both can and often should be coded together to capture the complete clinical picture. |
š Clinical Overview
Phenotype Distinction: Barrettās Progression
This table compares the progressive stages of Barrettās esophagus, which dictates the surveillance interval and correct ICD-10-CM assignment.
| Feature | K22.70 ā Without Dysplasia | K22.710 ā Low Grade Dysplasia | K22.711 ā High Grade Dysplasia |
|---|---|---|---|
| Cellular Architecture | Intestinal metaplasia only | Mild atypical cellular changes | Severe atypia, carcinoma in situ |
| Cancer Risk | Very Low (~0.1% to 0.3% per year) | Moderate (~1% per year) | High (~6% per year) |
| Typical Management | EGD Surveillance (every 3-5 years) | EGD Surveillance (annual) or Ablation | Endoscopic Eradication Therapy (RFA, EMR) |
CDI Query Trigger ā Pathology Disconnect
If an EGD is performed and the providerās postoperative diagnosis is āBarrettās esophagusā (K22.70), but the finalized pathology report returns a week later showing āBarrettās mucosa with low-grade dysplasia,ā a query must be sent to the provider. The provider must officially add the dysplasia finding to the diagnostic statement so the coder can capture K22.710.
Manifestations & Symptom Burden
Barrettās esophagus itself is often asymptomatic; symptoms are typically driven by the underlying GERD:
-
Chronic Pyrosis (Heartburn): Persistent burning sensation behind the sternum.
-
Acid Regurgitation: Sour fluid backing into the throat.
-
Dysphagia: Difficulty swallowing, which may indicate stricture formation or disease progression.
Coding Manifestations
Always code the documented underlying conditions or manifestations to fully capture patient complexity. Examples include:
K21.00 ā Gastro-esophageal reflux disease with esophagitis, without bleeding
K44.9 ā Diaphragmatic hernia without obstruction or gangrene
š° HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | ā Not HCC-Mapped |
| HCC Category | N/A |
| RAF Coefficient | N/A |
K22.70 does not map to an HCC under v28.
Capture Annually
Although not an HCC-mapped chronic condition for risk adjustment, capturing K22.70 is vital for proving medical necessity. It justifies the ongoing prescription of high-dose proton pump inhibitors (PPIs) and validates the medical need for routine surveillance endoscopies, which would otherwise be denied by payers if coded simply as GERD.
š„ DRG Assignment
MDC 06 ā Diseases and Disorders of the Digestive System
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 391 | Esophagitis, Gastroenteritis and Misc Digestive Disorders with MCC | ~1.15 |
| DRG 392 | Esophagitis, Gastroenteritis and Misc Digestive Disorders without MCC | ~0.70 |
Approximate. Verify against IPPS FY2026 Final Rule tables.
Sequencing and Complications
K22.70 is exceptionally rare as a principal diagnosis for an inpatient admission unless the patient is admitted for a therapeutic endoscopic intervention directly related to the esophagus (like an ablation). It is generally a secondary diagnosis found in the history and does not act as a CC or MCC.
š Related ICD-10-CM Codes
Progression / Exacerbation Variants
| Code | Description |
|---|---|
| K22.70 | Barrettās esophagus without dysplasia ā This Code |
| K22.710 | Barrettās esophagus with low grade dysplasia |
| K22.711 | Barrettās esophagus with high grade dysplasia |
Etiology and Alternative Diagnoses
| Code | Description |
|---|---|
| K21.9 | Gastro-esophageal reflux disease without esophagitis |
| K22.2 | Esophageal obstruction (Stricture) |
| C15.5 | Malignant neoplasm of lower third of esophagus |
š ļø Commonly Associated CPT Codes (Outpatient & Profee)
Outpatient and Profee Setting Context
K22.70 is a high-frequency diagnosis in ambulatory GI settings, used heavily to justify diagnostic endoscopies (with biopsy) for disease surveillance.
| CPT Code | Description | Profee Coding Notes (Modifier 26) |
|---|---|---|
| 43235 | EGD, flexible, transoral; diagnostic | Base diagnostic procedure. |
| 43239 | EGD, flexible, transoral; with biopsy, single or multiple | The most common CPT billed with K22.70 to check for dysplasia. |
| 43227 | Esophagoscopy, flexible, transoral; with control of bleeding | Billed if a bleeding Barrettās ulcer requires intervention. |
NCCI Bundling Considerations
- 43235 (Diagnostic EGD) billed on the same day as 43239 (EGD with biopsy). The diagnostic scope is inherently bundled into the surgical/biopsy code. Report only 43239.
š¬ ICD-10-PCS Crosswalk (Inpatient Procedures)
When K22.70 is an inpatient diagnosis, these PCS codes are relevant for associated inpatient procedures.
| PCS Section | Body System | Root Operation | Clinical Application |
|---|---|---|---|
| 0 (Medical/Surgical) | D (Gastrointestinal System) | B (Excision) | EGD with biopsy of the distal esophagus: 0DB58ZX (Excision of Lower Esophagus, Via Natural or Artificial Opening Endoscopic, Diagnostic). |
| 0 (Medical/Surgical) | D (Gastrointestinal System) | J (Inspection) | Diagnostic EGD performed to evaluate mucosal healing: 0DJ08ZZ (Inspection of Upper Intestinal Tract, Via Natural or Artificial Opening Endoscopic). |
š Coding Scenarios and Examples
Scenario 1 ā Outpatient Ambulatory Surgery Center: Surveillance EGD
Clinical Vignette: A 58-year-old male with a known history of Barrettās esophagus presents for his 3-year surveillance EGD. He has a history of severe GERD, currently managed with daily omeprazole. The EGD shows a 3 cm segment of salmon-colored mucosa in the distal esophagus. Four-quadrant biopsies are taken. The final pathology report confirms intestinal metaplasia with no evidence of dysplasia.
CPT / HCPCS (Profee):
- 43239 ā EGD, flexible, transoral; with biopsy, single or multiple
ICD-10-CM Diagnoses:
-
K22.70 ā Barrettās esophagus without dysplasia (Primary indication for the procedure and confirmed by pathology).
-
K21.9 ā Gastro-esophageal reflux disease without esophagitis (Underlying condition being medically managed).
Scenario 2 ā Inpatient Hospitalization: Secondary Diagnosis
Clinical Vignette: A 65-year-old female is admitted for a severe COPD exacerbation requiring IV steroids and BiPAP. During the admission, the hospitalist notes her home medications include Dexilant. The patient states this is for her āBarrettās esophagus,ā which was diagnosed via scope last year without any precancerous cells. The hospitalist continues the Dexilant on the inpatient MAR to prevent acid reflux while she is on steroids.
Principal Diagnosis:
- J44.1 ā Chronic obstructive pulmonary disease with (acute) exacerbation (Reason for admission).
Secondary Diagnoses:
- K22.70 ā Barrettās esophagus without dysplasia (Condition was actively managed/treated with medication during the stay).
MS-DRG Assignment: Groups to DRG 190 (COPD with MCC) or 191/192 (with CC or without CC/MCC), depending on other secondary diagnoses. K22.70 acts as a standard secondary diagnosis and does not elevate the DRG weight.
Scenario 3 ā CDI Query: Missing Pathology Confirmation
Clinical Vignette: A patient is seen in the GI clinic for a follow-up 2 weeks after an EGD. The providerās note states: āReview of path results from recent EGD. Patient has Barrettās esophagus. Will switch from pantoprazole to rabeprazole and follow up in 1 year.ā The attached pathology report states: āEsophageal mucosa: Intestinal metaplasia with low-grade dysplasia.ā
Action / Outcome:
The providerās diagnosis of āBarrettās esophagusā defaults to K22.70 (without dysplasia). However, the pathology report clearly indicates low-grade dysplasia. A coder cannot code directly from the pathology report to override the providerās diagnosis; a CDI query must be sent to bridge this clinical gap.
Query Response: Provider updates the clinical assessment to state: āBarrettās esophagus with low-grade dysplasia.ā
Corrected ICD-10-CM Coding:
- K22.710 ā Barrettās esophagus with low grade dysplasia (Accurately captures the severity risk and justifies the 1-year follow-up plan).
ā ļø Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| ā | Coding from Pathology Without Provider Linkage. You cannot assign K22.71- (with dysplasia) based solely on a pathology report if the provider only documented āBarrettās esophagus.ā You must query the provider to document the dysplasia in the official medical record. |
| ā | Omitting GERD. Do not assume GERD is inherently bundled into K22.70. If the provider documents both GERD and Barrettās, you should assign both K21.- and K22.70. |
| ā | Default to K22.70. If the provider documents āBarrettās esophagusā and there is no mention of dysplasia anywhere in the record or path report, assign K22.70. It is the default code for unspecified Barrettās. |
| ā | Check the Location. Barrettās esophagus almost exclusively affects the distal (lower) third of the esophagus. If coding inpatient procedures (PCS), ensure you select the āLower Esophagusā body part value (5) rather than upper or middle. |
š Sources
-
CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026.
-
American College of Gastroenterology (ACG). Clinical Guideline: Diagnosis and Management of Barrettās Esophagus.
-
CMS. IPPS Final Rule FY2026 ā MS-DRG Definitions Manual v43. MDC 06 logic tables.
-
AMA. CPT Professional Edition 2026. Surgery / Digestive System.
Crystal's Coder Hub